Prestige Consumer Healthcare
PBH
#3921
Rank
A$4.21 B
Marketcap
A$87.58
Share price
-0.31%
Change (1 day)
-33.16%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$6.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.76. In 2024 the company made an earnings per share (EPS) of A$6.10 an increase over its 2023 EPS that were of A-$2.28.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$6.364.15%
2024A$6.10-367.08%
2023A-$2.28-138.33%
2022A$5.9611.7%
2021A$5.3413.6%
2020A$4.70-651.67%
2019A-$0.85-148.78%
2018A$1.75-83.29%
2017A$10.45437.23%
2016A$1.94-34.13%
2015A$2.9552.94%
2014A$1.93-8.11%
2013A$2.10
2011A$1.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.81 174.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$9.81 70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.45 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.93-66.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.32-7.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.73 51.48%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$0.57-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.35-7.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.04-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.73-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel